Clinical trials: Diabetes Insipidus
Nocturnal Enuresis
Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).
Monosymptomatic nocturnal enuresis (MEN) is a common problem in children, affecting 7-10% of all 7 year olds. MEN is often leading to psychosocial problems because of its burden and stigmatism.
- Trial name
- COMEN (NCT02621736)
- Testing
- blood sampling
- Where
- Switzerland
- Volunteers
- 28 people
- Sponsor
- University Hospital, Basel, Switzerland
Injury
Serum Vasopressin Levels and Severe Hemorrhagic Shock
The purpose of this study is to determine if vasopressin is used up by the body during traumatic shock (severe low blood pressure due to trauma).
- Trial name
- NCT01676454
- Where
- United States
- Sponsor
- Poudre Valley Health System
Leiomyoma, Laparoscopy
Combined Vaginal Misoprostol and Perivascular Vasopressin
Injection of Vasopressin into the uterine tissue surrounding fibroids constricts blood vessels, and has been found to be beneficial by decreasing blood flow to fibroids, and thereby resulting in less bleeding with removal.
- Conditions
- Leiomyoma, Laparoscopy, Uterine Myomectomy
- Trial name
- NCT03815344
- Testing
- Standard, Standard-vaginal misoprostol
- Where
- United States
- Volunteers
- 74 people, healthy volunteers welcome
- Sponsor
- Antonios Likourezos
Diabetes Insipidus
Metformin and Congenital Nephrogenic Diabetes Insipidus
The purpose of this study is to determine whether metformin can increase urine concentration (osmolality) and decrease the amount of urine in patients with congenital nephrogenic diabetes insipidus (NDI).
- Trial name
- NCT02460354
- Testing
- Metformin
- Where
- 3 sites in United States
- Volunteers
- 2 people
- Sponsor
- Emory University
Healthy
Effects of Oxytocin and Vasopressin on Moral Decision Making
To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making
- Trial name
- NCT04890470
- Testing
- Oxytocin, Vasopressin
- Where
- China
- Volunteers
- 180 people, healthy volunteers welcome
- Sponsor
- University of Electronic Science and Technology of China
Septic Shock
Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication
The aim of this observational study is to examine real-world clinical practice regarding the use of vasopressin as a second-line vasopressor in adult patients admitted to Intensive Care Units (ICUs) with septic shock.
- Trial name
- VASO-2024 (NCT07255378)
- Testing
- Usage of vasopressin (VAP) as a second-line vasopressor in septic shock patients.
- Where
- 12 sites in Spain
- Volunteers
- 1,200 people
- Sponsor
- Jamil Cedeño Mora